US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors
Patent 9271978 was granted and assigned to Zenith Epigenetics Corp. on March, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.